I totally get your concern it’s a valid one. The fact is once...

I totally get your concern it’s a valid one. The fact is once you’re actually on the ground and dealing with commercialization, the reality is a bit different than being in a lab, also being a novel tec make things harder too - adoption is normally slow in healthcare and EXPENSIVE. For example It all started with XV LVAS as the flagship product - then customer feedback pushed things toward CT-based solutions, so 4DMedical shifted and got CT LVAS approved.Another is example is the VA component, when Trump came in that threw a lot of things up in the air despite all the progress that was made.

I can give more examples but that said, company have achieved so many things and foundations for success are so sloid and never been more stronger, its not game over yet.

Now that Philips is selling our products, and with CT VQ expected to land this year we should star seeing some solid deals and contracts coming through in the near future. For all doubter out thereCT:VQ is the final trick up the sleeve for 4DX — and in my opinion, despite the pushbacks and delays I’m still hopeful and optimistic - I believe this is destined for success - its never meant to be an easy ride this isn't how life works. I’m also not too worried about another capital raise or dilution simply because the potential upside is HUGE if/once they deliver.

I can be wrong this is my personal opinion and not a financial advice. GLTAH